Published in Mol Cell Biol on August 01, 1994
PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J (1998) 1.84
Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J (1997) 1.73
Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci U S A (1996) 1.71
PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol (1995) 1.70
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63
Retracted TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937. Genes Dev (2001) 1.46
The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J Exp Med (1996) 1.30
Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol Cell Biol (1997) 1.20
PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis. J Cell Mol Med (2009) 0.96
Combinatorial determinants of tissue-specific transcription in B cells and macrophages. Mol Cell Biol (1997) 0.92
Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription. Mol Cell Biol (1996) 0.92
Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature (1989) 9.08
Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell (1988) 8.00
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell (1990) 8.00
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science (1992) 6.09
Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science (1992) 5.71
The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature (1993) 5.24
Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev (1989) 5.09
A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell (1992) 4.96
Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J (1993) 4.35
Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature (1993) 4.20
Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes. Biochemistry (1987) 4.16
ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A (1990) 4.11
Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science (1993) 3.78
Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature (1993) 3.73
Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev (1990) 3.65
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature (1988) 3.59
Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol Cell Biol (1989) 3.49
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor. EMBO J (1991) 3.28
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A (1993) 2.90
The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol (1994) 2.69
Structure and evolution of a human erythroid transcription factor. Nature (1990) 2.47
Interactions of alpha- and gamma-interferon in the transcriptional regulation of the gene encoding a guanylate-binding protein. EMBO J (1989) 2.39
Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell (1993) 2.29
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem (1993) 2.20
The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol Cell Biol (1993) 2.06
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science (1993) 2.06
Isolation and expression of functional high-affinity Fc receptor complementary DNAs. Science (1989) 2.06
Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3. Proc Natl Acad Sci U S A (1993) 1.99
Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. Science (1993) 1.96
Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by gamma-interferon is mediated through common DNA response elements. Proc Natl Acad Sci U S A (1991) 1.93
A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem (1991) 1.83
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol (1992) 1.81
Characterization of a new megakaryocytic cell line: the Dami cell. Blood (1988) 1.58
The PU.1 transcription factor is the product of the putative oncogene Spi-1. Cell (1990) 1.52
Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol Cell Biol (1991) 1.52
Interferon gamma rapidly induces in human monocytes a DNA-binding factor that recognizes the gamma response region within the promoter of the gene for the high-affinity Fc gamma receptor. Proc Natl Acad Sci U S A (1992) 1.46
In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Mol Cell Biol (1993) 1.44
Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element. Genes Dev (1993) 1.37
Characterization of the myeloid-specific CD11b promoter. Blood (1992) 1.28
Interferon-dependent signaling pathways: DNA elements, transcription factors, mutations, and effects of viral proteins. J Interferon Res (1992) 1.27
5' regulatory region of a novel cytokine gene mediates selective activation by interferon gamma. J Exp Med (1991) 1.22
The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors. Oncogene (1990) 1.21
Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism. Mol Cell Biol (1993) 1.17
The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage. Mol Cell Biol (1993) 1.11
Establishment and characterization of a new human eosinophilic leukemia cell line. Blood (1985) 1.08
Constitutive monocyte-restricted activity of NF-M, a nuclear factor that binds to a C/EBP motif. J Immunol (1992) 1.08
Definition of interferon gamma-response elements in a novel human Fc gamma receptor gene (Fc gamma RIb) and characterization of the gene structure. J Exp Med (1992) 1.06
Identification of cell-specific and developmentally regulated nuclear factors that direct myeloid and lymphoid expression of the CD11a gene. Proc Natl Acad Sci U S A (1993) 0.93
Cell adhesion markers are expressed by a stable human endothelial cell line transformed by the SV40 large T antigen under vimentin promoter control. J Cell Physiol (1993) 0.87
Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol (1988) 4.04
Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem (2000) 2.10
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J (1993) 1.83
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol (1992) 1.81
Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry (1974) 1.79
PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene (1995) 1.76
Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur J Immunol (1984) 1.58
Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand (1988) 1.57
Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol Cell Biochem (1975) 1.55
Emergence of tumorigenic cells during the course of Friend virus leukemias. Proc Natl Acad Sci U S A (1981) 1.52
Physico-chemical characterization and partial purification of mouse immune interferon. J Gen Virol (1979) 1.49
Expression of Ia antigens by cultured astrocytes treated with gamma-interferon. Neurosci Lett (1983) 1.48
Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6'-trehalose dimycolate). J Infect Dis (1977) 1.40
The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb. J Biol Chem (1996) 1.26
DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene (1995) 1.23
The human homologue of the putative proto-oncogene Spi-1: characterization and expression in tumors. Oncogene (1990) 1.21
The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J Biol Chem (1998) 1.20
Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism. Mol Cell Biol (1993) 1.17
IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene (2000) 1.14
IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J Immunol (1991) 1.12
Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin Exp Immunol (2002) 1.08
Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens. J Immunol (1985) 1.07
Structural study of the poly-l-Glutamic acid of the cell wall of Mycobacterium tuberculosis var hominis, strain Brevannes. Biochem Biophys Res Commun (1975) 1.06
Recombinant tumor necrosis factors mediate platelet cytotoxicity to Schistosoma mansoni larvae. J Immunol (1988) 1.02
Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J Immunol (1992) 1.01
Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha. Eur J Immunol (1992) 1.01
Production of antibodies against mouse immune T (type II) interferon and their neutralizing properties. J Gen Virol (1980) 1.01
Isolation and characterization of a gp 70+ non producer Friend tumor cell clone. Biochimie (1983) 1.00
Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene. Oncogene (2006) 0.99
Treatment of multiple sclerosis patients with interferon-beta primes monocyte-derived macrophages for apoptotic cell death. J Leukoc Biol (2001) 0.99
Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. Eur J Immunol (1990) 0.98
IFN-gamma is an essential cosignal for triggering IFN-beta 2/BSF-2/IL-6 gene expression in human monocytic cell lines. Ann N Y Acad Sci (1989) 0.98
Differential regulation of 4E-BP1 and 4E-BP2, two repressors of translation initiation, during human myeloid cell differentiation. J Immunol (1999) 0.98
Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J (1993) 0.98
Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-gamma levels. Biochimie (1999) 0.96
Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. J Immunol (1986) 0.95
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene (2000) 0.94
Affinity chromatographic analysis of murine interferons induced by viruses and by T and B cell stimulants. Ann Immunol (Paris) (1977) 0.94
Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma. J Immunol (1987) 0.94
Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene (1996) 0.94
Friend leukemia as a multiple-step disease. Blood Cells (1981) 0.93
Localization of the human oncogene SPI1 on chromosome 11, region p11.22. Hum Genet (1990) 0.93
Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells. Oncogene (2000) 0.93
Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem Biophys Res Commun (1998) 0.93
Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides. Oncogene (1994) 0.93
Integration of spleen focus-forming virus proviruses in Friend tumor cells. J Virol (1985) 0.92
Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages. Biochem J (1994) 0.92
Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo. Ann Inst Pasteur Immunol (1987) 0.91
Analysis of integrated proviral DNA sequences with an octadecanucleotide probe designed for specific identification of spleen focus-forming virus in the mouse genome. J Virol (1986) 0.89
Some properties of interferons induced by stimulants of T and B lymphocytes. Tex Rep Biol Med (1977) 0.89
Relationship among circulating interferon, tumor necrosis factor-alpha, and interleukin-6 and serologic reaction against parasitic antigen in human hydatidosis. J Interferon Cytokine Res (1997) 0.89
Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells. Biochem Biophys Res Commun (1998) 0.89
Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages. Clin Exp Immunol (1999) 0.88
Control of Ia antigen expression on phagocytic cells of the thymic reticulum by interferon-gamma and prostaglandins. Eur J Immunol (1986) 0.88
Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Hum Genet (1992) 0.87
IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A3 class I genes. J Immunol (1989) 0.87
Interaction of 14C-labelled amphotericin B derivatives with human erythrocytes: relationship between binding and induced K+ leak. Biochim Biophys Acta (1988) 0.87
Induction of interferon by mycoplasmas in mouse spleen cell cultures. J Interferon Res (1982) 0.87
Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats. Parasitol Res (2001) 0.86
Antagonistic action of IFN-beta and IFN-gamma on high affinity Fc gamma receptor expression in healthy controls and multiple sclerosis patients. J Immunol (1998) 0.86
DMSO reduces CSF-1 receptor levels and causes apoptosis in v-myc immortalized mouse macrophages. Exp Cell Res (1998) 0.86
Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation. Oncogene (1998) 0.85
Immune interferon induced by phytohemagglutinin in nude mouse spleen cells. Infect Immun (1978) 0.85
Human endothelial cells transfected by SV40 T antigens: characterization and potential use as a source of normal endothelial factors. Eur J Immunol (1992) 0.85
IFN-gamma reduces specific binding of tumor necrosis factor on murine macrophages. J Immunol (1991) 0.85
Properties of mouse immune T-interferon (type II). Ann N Y Acad Sci (1980) 0.84
Presence of a polynucleotide binding site on murine immune interferon (T-type). Biochem Biophys Res Commun (1978) 0.84
Epigenetic silencing of Bim transcription by Spi-1/PU.1 promotes apoptosis resistance in leukaemia. Cell Death Differ (2013) 0.84
Inactivation of interleukin-6 in vitro by monoblastic U937 cell plasma membranes involves both protease and peptidyl-transferase activities. Eur J Biochem (1993) 0.84
Semaxinib (SU5416) as a therapeutic agent targeting oncogenic Kit mutants resistant to imatinib mesylate. Oncogene (2006) 0.84
Levels of tumor necrosis factor alpha, gamma interferon, and interleukins 4,6, and 10 as determined in mice infected with virulent or attenuated strains of Trypanosoma cruzi. Parasitol Res (1999) 0.84
Effects of 2-deoxy-D-glucose on the glucose metabolism in Saccharomyces cerevisiae studied by multinuclear-NMR spectroscopy and biochemical methods. Biochimie (1992) 0.83
TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma: dependence on alpha 5 beta 1 and beta 2 integrins. Exp Cell Res (1996) 0.83
Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma. J Immunol (1987) 0.83
Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acid. Int Immunol (1993) 0.83
Expression of c-ras and c-myc oncogenes in murine erythroleukemias induced by Friend viruses. Leuk Res (1984) 0.83
Analysis of the cell wall of five strains of Myocbacterium tuberculosis BCG and of an attenuated human strain, W 115. Infect Immun (1976) 0.83
Alterations in interferon-gamma and nitric oxide levels in human echinococcosis. Cell Mol Biol (Noisy-le-grand) (2006) 0.82
IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J Immunol (1992) 0.82
Studies on purification of human gamma interferon: chromatographic behavior of accompanying IL2 and B-cell helper activity. J Interferon Res (1984) 0.82
Inhibition of gamma-glutamyl transpeptidase activity at the surface of human myeloid cells is correlated with macrophage maturation and transforming growth factor beta production. Cell Growth Differ (1995) 0.82
Modulation of murine and human interferon-gamma receptor expression by their ligands or phorbol ester. Cytokine (1994) 0.82
Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. J Invest Dermatol (1992) 0.82
TGF-beta-like activity produced during regression of exacerbations in multiple sclerosis. Acta Neurol Scand (1991) 0.82
Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gamma. Microbiol Immunol (1995) 0.82
Non-cooperative effects of glucose and 2-deoxyglucose on their metabolism in Saccharomyces cerevisiae studied by 1H-NMR and 13C-NMR spectroscopy. Eur J Biochem (1993) 0.81
A novel approach for investigating reaction mechanisms in cells. Mechanism of deoxy-trehalose synthesis in Saccharomyces cerevisiae studied by 1H-NMR spectroscopy. Eur J Biochem (1995) 0.81
Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2. Leukemia (2000) 0.81
Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha. Immunology (1990) 0.81
Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines. Eur J Immunol (1994) 0.81
Isolation and characterization of a chicken homologue of the Spi-1/PU.1 transcription factor. Oncogene (1998) 0.80
Phosphorylation of CD20 in cells from a hairy cell leukemia cell line. Evidence for involvement of calcium/calmodulin-dependent protein kinase II. J Immunol (1993) 0.80
Detection of tumorigenic cells in Friend virus-infected mice: an in vivo methodological investigation. J Natl Cancer Inst (1981) 0.79
General procedures for purification of mouse immune interferon. Methods Enzymol (1981) 0.79
Chemical structure of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG. Z Immunitatsforsch Exp Klin Immunol (1975) 0.79